Form 4 Tracker
Merck & Co., Inc.
MRK

66 insider filings · Latest: Jun 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 9, 2026Feb 13 9:15 PMCHIRFI GUINDO
Proposed Sale
20,000$118.41$2.4M

View →

Feb 12, 2026Feb 12 9:02 PMChirfi GuindoChief Marketing Officer
Sale
10,000$121.46$1.2M60,615.127(D)

View →

Feb 10, 2026Feb 10 9:38 PMDEAN LI
Proposed Sale
10,235$117.52$1.2M

View →

Feb 10, 2026Feb 10 9:04 PMDean Y LiExecutive VP & President, MRL
Sale
10,235$117.52$1.2M92,035.05(D)

View →

Feb 9, 2026Feb 9 9:57 PMJENNIFER ZACHARY
Proposed Sale
121,573$119.15$14.5M

View →

Feb 9, 2026Feb 9 9:55 PMCHIRFI GUINDO
Proposed Sale
20,000$118.41$2.4M

View →

Feb 9, 2026Feb 9 9:04 PMChirfi GuindoChief Marketing Officer
Sale
10,000$118.41$1.2M70,615.127(D)

View →

Feb 9, 2026Feb 9 9:01 PMJennifer ZacharyEVP, General Counsel
Sale
121,573$119.15$14.5M68,915.671(D)

View →

Feb 6, 2026Feb 6 9:35 PMRICHARD ROBERT DELUCA JR.
Proposed Sale
37,685$120.92$4.6M

View →

Feb 6, 2026Feb 6 9:33 PMDAVID WILLIAMS
Proposed Sale
5,000$121.91$609.5K

View →

Feb 6, 2026Feb 6 9:20 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Sale
5,000$121.91$609.5K30,837.743(D)

View →

Feb 6, 2026Feb 6 9:19 PMJOHANNES JACOBUS OOSTHUIZEN
Proposed Sale
15,000$121.87$1.8M

View →

Feb 4, 2026Feb 6 9:18 PMDalton E. Smart IIISVP Fin. - Global Controller
Sale
6,400$119.68$765.9K8,204.816(D)

View →

Feb 6, 2026Feb 6 9:15 PMJohannes Jacobus OosthuizenPresident, U.S. Market
Sale
15,000$121.87$1.8M21,197.389(D)

View →

Feb 4, 2026Feb 6 9:13 PMCaroline LitchfieldEVP & CFO
Sale
41,997$119.61$5.0M90,192.194(D)

View →

Feb 4, 2026Feb 6 9:12 PMDean Y LiExecutive VP & President, MRL
Sale
15,087$118.77$1.8M102,270.05(D)

View →

Feb 5, 2026Feb 6 9:10 PMChirfi GuindoChief Marketing Officer
Sale
20,000$121.88$2.4M80,615.127(D)

View →

Feb 6, 2026Feb 6 9:08 PMRichard R. DelucaEVP&Pres, Merck Animal Heallth
Sale
37,685$120.92$4.6M160,173.834(D)

View →

Feb 4, 2026Feb 6 9:05 PMRobert M DavisDirector, Chairman, CEO & President
Sale
47,434$118.04$5.6M443,601.757(D)

View →

Feb 5, 2026Feb 5 9:25 PMCHIRFI GUINDO
Proposed Sale
20,000$121.88$2.4M

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 29, 2026May 1 9:38 PMRobert M DavisDirector, Chairman, CEO & President
Option Exercise
13,30026,601(D)

View →

Apr 29, 2026May 1 9:34 PMJohannes Jacobus OosthuizenEVP, Oncology & Int?l
Option Exercise
1,3772,755(D)

View →

Mar 31, 2026Apr 1 5:47 PMChristine E SeidmanDirector
Grant/Award
67.54519,238.328(D)

View →

Mar 31, 2026Apr 1 5:44 PMThomas H GlocerDirector
Grant/Award
405.271108,293.493(D)

View →

Mar 31, 2026Apr 1 5:42 PMMary Ellen CoeDirector
Grant/Award
249.39729,702.652(D)

View →

Feb 9, 2026Feb 9 9:01 PMJennifer ZacharyEVP, General Counsel
Option Exercise
121,573$87.100(D)

View →

Feb 6, 2026Feb 6 9:20 PMDavid Michael WilliamsEVP,Chief Info&Digital Officer
Option Exercise
5,0004,600(D)

View →

Feb 4, 2026Feb 6 9:18 PMDalton E. Smart IIISVP Fin. - Global Controller
Option Exercise
4,000$62.078,130(D)

View →

Feb 4, 2026Feb 6 9:13 PMCaroline LitchfieldEVP & CFO
Option Exercise
41,9970(D)

View →

Feb 4, 2026Feb 6 9:12 PMDean Y LiExecutive VP & President, MRL
Option Exercise
15,0870(D)

View →

← Previous

Page 3 of 3